Wettig Thane reported KYNB

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001815638-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Feb 3, 2026

Published

Feb 5, 2026

Ingested by INSIDER

Nov 5, 04:18 UTC

Last re-read

Nov 5, 04:18 UTC

Extracted facts

Filer

Wettig Thane

Role

Director, CEO

Transaction

Grant or awardAs filed: “A”

Asset

KYNTRA BIO, INC. — Stock Option (Right to Buy)

Ticker

KYNB

Shares

60.0K

Price per share

$0

Execution date (reported)

Feb 3, 2026

Owned after transaction

60.0K shares

Days from execution to publication

2

What this establishes

Wettig Thane filed this Form 4 reporting a grant or award of KYNB on Feb 3, 2026. It became public on Feb 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, CEO

Wettig Thanecik:0001815638

Issuer

KYNTRA BIO, INC.cik:0000921299

Revision history · 0

No field has changed since this record was first ingested.